Walleye Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-18,001
| Closed | -$324K | – | 4944 |
|
|
2020
Q2 | $324K | Sell |
18,001
-20,471
| -53% | -$285K | ﹤0.01% | 2650 |
|
|
2020
Q1 | $274K | Buy |
38,472
+19,712
| +105% | +$246K | ﹤0.01% | 2365 |
|
|
2019
Q4 | $448K | Buy |
+18,760
| New | +$517K | ﹤0.01% | 2500 |
|
|
2019
Q2 | – | Sell |
-231
| Closed | -$7.24K | – | 4740 |
|
|
2019
Q1 | $8K | Sell |
231
-29,159
| -99% | -$841K | ﹤0.01% | 4016 |
|
|
2018
Q4 | $574K | Buy |
29,390
+11,958
| +69% | +$246K | ﹤0.01% | 2340 |
|
|
2018
Q3 | $464K | Buy |
17,432
+15,905
| +1,042% | +$519K | ﹤0.01% | 2979 |
|
|
2018
Q2 | $58K | Buy |
+1,527
| New | +$58.4K | ﹤0.01% | 4211 |
|
|
2017
Q3 | – | Sell |
-7,390
| Closed | -$415 | – | 4810 |
|
|
2017
Q2 | $415 | Buy |
7,390
+5,590
| +311% | +$224K | ﹤0.01% | 2558 |
|
|
2017
Q1 | $71 | Buy |
+1,800
| New | +$57.3K | ﹤0.01% | 3607 |
|
|
2016
Q2 | – | Sell |
-2,500
| Closed | -$51K | – | 5909 |
|
|
2016
Q1 | $51K | Buy |
+2,500
| New | +$79.3K | ﹤0.01% | 3848 |
|
|
2015
Q4 | – | Sell |
-300
| Closed | -$13K | – | 5908 |
|
|
2015
Q3 | $13K | Buy |
300
+200
| +200% | +$9.65K | ﹤0.01% | 4297 |
|
|
2015
Q2 | $5K | Buy |
+100
| New | +$4.02K | ﹤0.01% | 4517 |
|
Walleye Trading's PTLA Position: Q3 2020 in Review
Walleye Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 18,001 shares — an estimated $324K sold.
Walleye Trading first reported a position in PTLA in Q2 2015 and held it in 12 quarters. The position peaked at $574K in Q4 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Walleye Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Walleye Trading sold 18,001 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $324K.
- Walleye Trading first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 12 quarters.
- Walleye Trading's Portola Pharmaceuticals, Inc. position peaked at $574K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.